September 29, 2006 —The US Food and Drug Administration (FDA) has approved first-time generic formulations for caffeine citrate 10-mg/mL intravenous injection and 10-mg/mL oral solution for the ...
Schering-Plough Corp. lost a legal battle with generic-drug makers when a U.S. judge ruled that a patent on its top-selling Claritin allergy drug was invalid. Unless overturned on appeal, the ruling ...
NJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.
NEW YORK (AP) _ Under immense regulatory and competitive pressure, Schering-Plough Corp. said Friday it planned to switch its blockbuster allergy prescription medicine Claritin to an over-the-counter ...
NEW YORK (Reuters Health) - The "second generation" allergy drug desloratadine (brand name Clarinex) significantly reduces both the runny nose and congestion of seasonal and persistent allergic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results